Search
Clearpoint Neuro Inc
CLPTAdd to Watchlist
14.940USD
+0.360+2.47%
Close 07-31 16:00（ET）Quotes delayed by 15 min
448.04MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Clearpoint Neuro Inc is 8.67, ranking 20 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 29.00, with a high of 30.00 and a low of 28.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
28.333
Target Price
+89.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Clearpoint Neuro Inc
CLPT
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Clearpoint Neuro Inc's expected revenue for the next quarter?
Clearpoint Neuro Inc's expected revenue is 12.73M.
What is Clearpoint Neuro Inc's price target?
Analysts forecast that Clearpoint Neuro Inc's price target is USD 29.00, with the highest forecast at USD 30.00 and the lowest forecast at USD 28.00.
How have Clearpoint Neuro IncCLPT's recent earnings per share performed?
The market expectation was USD -0.32, while Clearpoint Neuro IncCLPT's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.29.
What is the analyst rating for Clearpoint Neuro Inc?
Based on the ratings of Clearpoint Neuro Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.